Covid-19 roundup: Pfiz­er sub­mits vac­cine for full ap­proval; Merkel op­pos­es Biden pro­pos­al to sus­pend IP for vac­cines

Pfiz­er and BioN­Tech said Fri­day that they’ve sub­mit­ted a bi­o­log­ics li­cense ap­pli­ca­tion to the FDA for full ap­proval of their mR­NA vac­cine for those over the age of 16.

How long it will take the FDA to de­cide on the BLA will be set once it’s been for­mal­ly ac­cept­ed by the agency.

Pe­ter Marks, di­rec­tor of the FDA’s Cen­ter for Bi­o­log­ics Eval­u­a­tion and Re­search, pre­vi­ous­ly told End­points News that the re­view of the BLA should take be­tween three and four months, but it may be even faster than that.

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER